Mi Young Park

Title: Mi Young Park - Innovator in Colorectal Cancer Research

Mi Young Park is a prominent inventor based in Jeonju-si, South Korea. She has made significant contributions to the field of cancer research, particularly in the diagnosis and treatment of colorectal cancer. Her work focuses on the characterization of ESM-1 as a tumor-associated marker, which has the potential to improve patient outcomes.

Latest Patents

Mi Young Park holds a patent titled "Characterization of ESM-1 as a tumor associated marker of colorectal cancer." This patent discloses a colorectal cancer marker for diagnosing the disease based on ESM-1 overexpression in tissues, cells, or body fluids of colorectal cancer patients. The patent also outlines the use of this marker in the development of therapeutic agents for cancer and in the diagnosis and treatment of colorectal cancer.

Career Highlights

Mi Young Park is affiliated with the Korea Research Institute of Bioscience and Biotechnology. Her work at this esteemed institution has allowed her to focus on innovative research that addresses critical health issues. With her expertise, she has contributed to advancing the understanding of colorectal cancer and its biomarkers.

Collaborations

Mi Young Park collaborates with notable colleagues, including Eun Young Song and Hyang Sin Lee. These partnerships enhance her research efforts and contribute to the development of effective diagnostic and therapeutic strategies for colorectal cancer.

Conclusion

Mi Young Park's innovative work in colorectal cancer research exemplifies the impact of scientific inquiry on healthcare. Her contributions through patents and collaborations are paving the way for advancements in cancer diagnosis and treatment.